Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Neuromyelitis Optica Spectrum Disorder
Related studies linked through entity extraction aliases.
CorEvitas SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions) Registry for Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Rituximab at Low dosE for neuromyelitiS optiCa spectrUm disordEr (RESCUE)
- Status
- COMPLETED
- Phase
- PHASE4
An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD
- Status
- COMPLETED
- Phase
- PHASE3
A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Comparison of the Efficacy and Safety of Immunoadsorption and Plasma Exchange for Acute Attack of Refractory Neuromyelitis Optica Spectrum Disorders
- Status
- UNKNOWN
- Phase
- PHASE2
French Registry for Monitoring Pregnancies for Multiple Sclerosis
- Status
- RECRUITING
- Phase
- N/A
Clinical Patterns of Neuromyelitis Optica Spectrum Disorders in Assiut University Hospital
- Status
- COMPLETED
- Phase
- N/A
Treatment of Relapsed and/or Refractory AQP4-IgG Seropositive NMOSD by Tandem CAR T Cells Targeting CD19 and CD20
- Status
- WITHDRAWN
- Phase
- PHASE1
Central Pain Study for ABX-1431
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of Clinical Effects of Azathioprine and Rituximab NMO-SD Patients
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Efficacy and Safety of Bortezomib as add-on Treatment in Relapsing Neuromyelitis Optica Spectrum Disorder
- Status
- COMPLETED
- Phase
- PHASE2
Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses
- Status
- COMPLETED
- Phase
- PHASE1
An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients
- Status
- COMPLETED
- Phase
- PHASE3
A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)
- Status
- TERMINATED
- Phase
- PHASE3
Phase II Clinical Trial of NPB-01 in Patients With Anti-aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder Not Provided Adequate Effect of Therapy to Steroids Plus Therapy.
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Bevacizumab (Avastin) in Treatment of Acute NMO Exacerbations
- Status
- COMPLETED
- Phase
- PHASE1
The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A